MENU
BLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioLineRx (BLRX) Ownership - Who owns BioLineRx?

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology... Show more

Profile

Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.71M
P/E Ratio
N/A
Total Cash
25.21M
Projected Growth
N/A
Total Debt
11.38M
Revenue
12.74M
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
5.79
Total Debt/Equity
N/A
Revenue/Share
3.59 USD as % of share price

Fundamentals

BLRX
Capitalization
13.7M
P/E Ratio
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash
25.2M
Total Cash/Share
5.79
Total Debt
11.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.59%
Revenue
12.7M
ROE
N/A
Book Value
19.5M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73.4M
Current Ratio
2.09
Current Revenue Per Employee
15250.00
Dividends Per Share - Security
N/A
EBITDA
4.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.33
Revenue To Assets
-6.43
Shares Held By Institutions
103K
Shares Outstanding - Current
4.35M
Total Liabilities
20.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-62.266
View a ticker or compare two or three
BLRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical development company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com